PropertyValue
?:abstract
  • Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outbroken and spread rapidly in Wuhan, Hubei, nationwide, and even other countries, with clustering cases Clinical manifestations include fever, fatigue, dry cough, and difficulty breathing, with or without upper respiratory tract symptoms such as nasal congestion and runny nose1 There is no evidence from randomized controlled trial to support the treatment of new anti-SARS-CoV-2 suspected or confirmed cases, and there is an urgent need to better understand this new virus and develop drugs to treat patients infected by the virus Based on previous research data, some drugs that may benefit clinically are summarized with a view to providing references for the diagnosis and treatment of SARS-CoV-2 in other medical institutions, as well as the rational choice of drugs and drug development
is ?:annotates of
?:creator
?:journal
  • Chinese_Journal_of_New_Drugs
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Summary on the potential therapeutics against severe acute respiratory syndrome coronavirus 2
?:type
?:who_covidence_id
  • #686436
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/uxxsyjzp>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/uxxsyjzp>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all